The pulmonary route has long been used for drug administration for both local and systemic
treatment. It possesses several advantages, which can be categorized into physiological, ie …

Therapeutic biologics such as genes, peptides, proteins, virus and cells provide clinical
benefits and are becoming increasingly important tools in respiratory medicine. Pulmonary …

Lipid nanoparticles are increasingly used for drug and gene delivery, including the delivery
of small interfering RNA (siRNA). Pulmonary delivery of drug molecules carried by lipid …

The global market of pharmaceutical biologics has expanded significantly during the last few
decades. Currently, pharmaceutical biologic products constitute an indispensable part of the …

Encapsulation of carotenoid enriched flaxseed oil was performed by spray freeze-drying by
using sixteen different emulsion formulations. Emulsions, which contain various …

Background The global healthcare sector has been dealing with a situation known as a
novel severe acute respiratory syndrome (SARS-CoV-2) since the end of 2019. Covid-19 is …

There is an urgent need to develop antiviral drugs and alleviate the current COVID‐19
pandemic. Herein we report the design and construction of chimeric oligonucleotides …

Pulmonary drug delivery has recognized benefits for both local and systemic treatments. Dry
powder inhalers (DPIs) are convenient, portable and environmentally friendly devices …

The prospect of inhaled biologics has garnered particular interest given the benefits of the
pulmonary route of administration. Pertinent considerations in producing inhalable dry …

The delivery of oligonucleotides such as siRNA to the lung is a major challenge, as this
group of drugs has difficulties to overcome biological barriers due to its polyanionic …